Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Public interest in finasteride's sexual side effects has significantly increased.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Low dose oral minoxidil is generally safe and can improve hair loss in women, with some experiencing side effects and minimal blood pressure changes.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Using both PRP and minoxidil together works better for treating hair loss in men than using either one alone.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

PRP injections may improve hair loss condition, but more research needed.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

LLLT increases hair density and growth in AGA patients.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.